Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Monocyte Activation in HIV
NCT01263938Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Sep 2011
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of atorvastatin in HIV-associated neurocognitive disorders (HAND), sponsored by University of Pennsylvania. Primary endpoints: Change in Monocyte Surface Markers Expression at 12 weeks, Change in Plasma Inflammatory Marker MCP-1 at 12 weeks and 2 more. Started Sep 2011; status: completed.
02
Drugs
atorvastatin
03
Conditions
HIV-associated neurocognitive disorders (HAND)
Beyond the preview
Go deeper on NCT01263938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01263938.